Peptide Answers

compound

IGF-1 LR3 (1mg Vial) Questions Answered

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified analog of human IGF-1 with significantly extended half-life, studied for its anabolic and metabolic effects [1] .

Read full protocol Calculate dose Find supplies TNHL ebooks
Educational reference only. TNHL does not diagnose, prescribe, or replace care from a licensed professional. Confirm all dosing, contraindications, and product decisions with qualified guidance.
Direct answer

IGF-1 LR3 (1mg Vial)

Week Daily Dose (mcg) Units (per injection) (mL) Weeks 1–2 20 mcg (0.02 mg) 6 units (0.06 mL) Weeks 3–4 40 mcg (0.04 mg) 12 units (0.12 mL) Weeks 5–8 50 mcg (0.05 mg) 15 units (0.15 mL) Frequency: Inject once daily subcutaneously, typically in the morning o...

Quickstart Highlights

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified analog of human IGF-1 with significantly extended half-life, studied for its anabolic and metabolic effects [1] .

Standard / Gradual Approach (3 mL = ~0.333 mg/mL)

Week Daily Dose (mcg) Units (per injection) (mL) Weeks 1–2 20 mcg (0.02 mg) 6 units (0.06 mL) Weeks 3–4 40 mcg (0.04 mg) 12 units (0.12 mL) Weeks 5–8 50 mcg (0.05 mg) 15 units (0.15 mL) Frequency: Inject once daily subcutaneously, typically in the morning o...

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration. Peptide Vials (IGF-1 LR3, 1 mg each): 8 weeks ≈ 3 vials (~2.24 mg total needed) 12 weeks ≈ 4 vials (~3.64 mg total needed) 16 weeks ≈ 6 vials (~5.04 mg total needed) Insulin Syringes (U-100,...

Important Notes

Practical considerations for consistency, safety, and optimal outcomes. Sterile technique: Always use new, sterile insulin syringes for each injection; dispose immediately in a sharps container [5] .